<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Celebrex and Bextra's Risk Up -- Seven Alternatives To Bring Your Risk &amp; Pain Down</title><link>http://articles.mercola.com/sites/articles/archive/2005/02/02/pain-risk.aspx</link><description>Due to the dangerous side effects associated with COX-2 inhibitors -- which are part of a larger class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDS) -- many of the nation's top drug makers, including No. 1 drug maker Pfizer, are expected</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>